$GNPX ~ “Aldevron is honored to partner with Genprex in the development of Oncoprex,” said Michael Chambers, CEO of Aldevron. “This collaboration furthers our goal to provide high-quality plasmid DNA and other biologics to leading companies such as Genprex that are creating treatments that could have a significant impact on human health.” https://finance.yahoo.com/news/genprex-taps-a...00040.html